2-({3-methyl-4-oxo-6-phenyl-3H,4H-thieno[3,2-d]pyrimidin-2-yl}sulfanyl)-N-phenylacetamide结构式
|
常用名 | 2-({3-methyl-4-oxo-6-phenyl-3H,4H-thieno[3,2-d]pyrimidin-2-yl}sulfanyl)-N-phenylacetamide | 英文名 | 2-({3-methyl-4-oxo-6-phenyl-3H,4H-thieno[3,2-d]pyrimidin-2-yl}sulfanyl)-N-phenylacetamide |
|---|---|---|---|---|
| CAS号 | 1105251-52-2 | 分子量 | 407.5 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C21H17N3O2S2 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | 2-({3-methyl-4-oxo-6-phenyl-3H,4H-thieno[3,2-d]pyrimidin-2-yl}sulfanyl)-N-phenylacetamide |
|---|
| 分子式 | C21H17N3O2S2 |
|---|---|
| 分子量 | 407.5 |
| InChIKey | UYCBCTISQVQQGH-UHFFFAOYSA-N |
| SMILES | Cn1c(SCC(=O)Nc2ccccc2)nc2cc(-c3ccccc3)sc2c1=O |
|
实验名称:High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS1303
|